Democratic lawmakers are at odds with the Biden administration about whether or not to permanently make nearly 5,000 fentanyl-like substances schedule I drugs.
Democratic lawmakers are at odds with the Biden administration about whether or not to permanently make nearly 5,000 fentanyl-like substances schedule I drugs.